Dr. Figeuroa is the principal scientist for EMulate Therapeutics overseeing pre-clinical research and the application of EMulate Therapeutics technology in multiple disease areas. He has more than 20 years of experience in basic and neurological clinical research, including Alzheimer’s research, neuron biology, cancer research, bioengineering and biophysics.
He has advised emerging biotechnology companies, most notably Cytokinetics and ENG3. Xavier has also served on non-profit Scientific Advisory Boards for such organizations as the Brain Health and Healing Foundation and has published broadly in multiple areas of science and medicine.
Dr. Figeuroa received his doctoral degree in Neurobiology & Behavior from the University of Washington. His doctoral training was followed by two post-doctoral fellowships within the University of Washington’s Department of Bioengineering. He is currently an affiliate assistant professor in the School of Medicine at the University of Washington.
Research Areas
Specialties: Molecular Biology, Toxicology, Photolithography, Cell Culture, Signal Transduction Pathways, Apoptosis Signaling and Regulation, Cancer Biology Expertise, Cell-Based Assays, Neuroscience and Neurodegenerative Expertise, Protein Isolation and Purification, Microfluidic Device Development, Clinical Trial Coordinator, Clinical Trial Project Manager.